Special Investigation in Patients With Psoriasis Vulgaris and Psoriatic Arthritis (All Patients Investigation)

Study Identifier
P12-077
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Study Details

Medical Condition
  • Dermatology - Psoriasis (PsO)
  • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years

    Protocol Summary

    The survey will be conducted with regard to the following aspects of treatment with Humira (adalimumab) in patients with psoriasis vulgaris and psoriatic arthritis receiving this drug:

    • unknown adverse drug reactions, especially clinically significant adverse reactions
    • incidence and conditions of occurrence of adverse reactions in the clinical setting
    • factors that may affect the safety and effectiveness of Humira.

    Study Locations

    Location
    Status
    Location
    Site Reference ID/Investigator# 41606
    Aichi, Japan
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 41769
    Aichi, Japan
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 41810
    Aichi, Japan
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 56131
    Aichi, Japan
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 56251
    Aichi, Japan
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 56252
    Aichi, Japan
    Status
    Not applicable
    Showing {first} - {last} of {total} Results